ATE193203T1 - Liposomale defensine - Google Patents

Liposomale defensine

Info

Publication number
ATE193203T1
ATE193203T1 AT94932006T AT94932006T ATE193203T1 AT E193203 T1 ATE193203 T1 AT E193203T1 AT 94932006 T AT94932006 T AT 94932006T AT 94932006 T AT94932006 T AT 94932006T AT E193203 T1 ATE193203 T1 AT E193203T1
Authority
AT
Austria
Prior art keywords
defensins
treatment
liposomal
release
liposomes
Prior art date
Application number
AT94932006T
Other languages
English (en)
Inventor
Andrew S Janoff
Walter Perkins
Imran Ahmad
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ATE193203T1 publication Critical patent/ATE193203T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Glass Compositions (AREA)
AT94932006T 1993-10-25 1994-10-25 Liposomale defensine ATE193203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14269193A 1993-10-25 1993-10-25
PCT/US1994/012167 WO1995011670A1 (en) 1993-10-25 1994-10-25 Liposomal defensins

Publications (1)

Publication Number Publication Date
ATE193203T1 true ATE193203T1 (de) 2000-06-15

Family

ID=22500893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94932006T ATE193203T1 (de) 1993-10-25 1994-10-25 Liposomale defensine

Country Status (13)

Country Link
US (1) US5766624A (de)
EP (1) EP0725629B1 (de)
JP (1) JP4076026B2 (de)
KR (1) KR960704524A (de)
AT (1) ATE193203T1 (de)
AU (1) AU680702B2 (de)
CA (1) CA2172955C (de)
DE (1) DE69424680T2 (de)
DK (1) DK0725629T3 (de)
ES (1) ES2146668T3 (de)
GR (1) GR3034259T3 (de)
PT (1) PT725629E (de)
WO (1) WO1995011670A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
US7262173B2 (en) 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US6126965A (en) * 1997-03-21 2000-10-03 Georgetown University School Of Medicine Liposomes containing oligonucleotides
US6984622B2 (en) * 1998-03-25 2006-01-10 The Regents Of The University Of California Use of lipopolysaccharides to manage corneal infections and wounds
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
CA2417331C (en) * 2000-07-28 2011-03-22 Christopher J. Murphy Transplant media comprising bnp-1
US6782459B1 (en) * 2000-08-14 2004-08-24 Rambus, Inc. Method and apparatus for controlling a read valid window of a synchronous memory device
WO2002060468A2 (en) * 2001-01-30 2002-08-08 University Of Iowa Research Foundation Antiviral activities of primate theta defensins and mammalian cathelicidins
US7550558B2 (en) * 2001-06-01 2009-06-23 Fundacao De Ampara A Pesquiso Do Estado De Sao Paolo (Fapesp) Antimicrobial peptides and methods for identifying and using such peptides
US6924052B2 (en) 2002-04-24 2005-08-02 General Motors Corporation Coolant flow field design for fuel cell stacks
US6866955B2 (en) * 2002-05-22 2005-03-15 General Motors Corporation Cooling system for a fuel cell stack
CA2508273A1 (en) * 2002-12-19 2004-07-08 Yitzchak Hillman Disease treatment via antimicrobial peptide inhibitors
CA2526878A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
US20060008466A1 (en) * 2004-07-07 2006-01-12 University Of Saskatchewan Methods for treating and preventing microbial infections
US20060263663A1 (en) * 2005-05-19 2006-11-23 Fowler Sitima R Temperature management of an end cell in a fuel cell stack
US9044438B2 (en) 2005-06-17 2015-06-02 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
US8202835B2 (en) 2005-06-17 2012-06-19 Yitzchak Hillman Disease treatment via antimicrobial peptides or their inhibitors
DE102005031206A1 (de) * 2005-07-01 2007-01-11 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Verfahren zur Untersuchung von Liposomen
US9732324B2 (en) 2008-10-23 2017-08-15 Cornell University Anti-viral method
GB0821687D0 (en) 2008-11-28 2008-12-31 Secr Defence Peptides
GB0821707D0 (en) * 2008-11-28 2008-12-31 Secr Defence Peptides
RU2016133412A (ru) * 2009-08-24 2018-12-10 Фидженикс, Инк. Целенаправленное воздействие на pax2 для лечения рака молочной железы
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
RS63786B1 (sr) * 2015-12-15 2022-12-30 Medicell Technologies Llc Kompozicije za stimulisanje matičnih ćelija i postupci za lečenje melazme

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621479A5 (de) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
US5169637A (en) * 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
US5252263A (en) * 1986-06-16 1993-10-12 The Liposome Company, Inc. Induction of asymmetry in vesicles
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4981690A (en) * 1987-10-27 1991-01-01 Board Of Regents, The University Of Texas System Liposome-incorporated mepartricin
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US4962277A (en) * 1988-12-09 1990-10-09 Scripps Clinic And Research Foundation Deletion analogues of magainin peptides
AU6428890A (en) * 1989-09-12 1991-04-18 Regents Of The University Of California, The Therapeutic peptides and proteins
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5045531A (en) * 1989-12-18 1991-09-03 Magainin Sciences Inc. Wound treatment employing biologically active ion channel forming peptides and proteins
US5279833A (en) * 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells

Also Published As

Publication number Publication date
KR960704524A (ko) 1996-10-09
DK0725629T3 (da) 2000-08-07
DE69424680T2 (de) 2000-09-28
CA2172955A1 (en) 1995-05-04
WO1995011670A1 (en) 1995-05-04
ES2146668T3 (es) 2000-08-16
EP0725629B1 (de) 2000-05-24
JP4076026B2 (ja) 2008-04-16
JPH09504298A (ja) 1997-04-28
EP0725629A1 (de) 1996-08-14
US5766624A (en) 1998-06-16
GR3034259T3 (en) 2000-12-29
AU680702B2 (en) 1997-08-07
AU8088894A (en) 1995-05-22
CA2172955C (en) 2002-12-24
DE69424680D1 (de) 2000-06-29
PT725629E (pt) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69424680D1 (de) Liposomale defensine
TW359613B (en) Tricot-like pouch for the delivery of topical drugs and cosmetics
FI963696A0 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
DE69434418D1 (de) Orale Dareichungsform
TW429152B (en) A tretinoin aqueous gel composition for therapeutic topical administration to the skin
ES2118834T3 (es) Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos.
FI955583A0 (fi) Nikotiinia sisältävä nasaalinen lääkkeenjakelukoostumus
FI941771A (fi) Tehostettu ihonläpäisyjärjestelmä lääkeaineiden parannettua paikallista antoa varten
DK0782448T3 (da) Ikke-irriterende, ikke-sensibiliserende, ikke-ototoksiske antibakterielle ørepræparater
IL122248A (en) Use of nisin in the manufacture of a medicament for the treatment of an infection and pharmaceutical compositions comprising nisin for said treatment
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
ES2180629T3 (es) Usos terapeuticos de productos dimeros de proteina bactericida/aumentadora de la permeabilidad.
ZA200600027B (en) Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
SE9804614D0 (sv) New peptides and use thereof
TWI264312B (en) Highly flexible transdermal therapeutic system with nicotine as active ingredient
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
AU5643299A (en) Humic acid and its use in the treatment of various conditions
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
ITRM920206A1 (it) Impiego di preparati contenenti cromo e vitamine e e c per il controllo del metabolismo glucidico e lipidico.
FR2683147B1 (fr) Systeme vehicule de principe actif permettant l'administration voie orale chez les poissons et crustaces.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee